Series - Policy

As life sciences companies rethink global supply chains, reshoring has become a strategic priority. But where in the U.S. can companies scale efficiently, access skilled talent, and remain cost-competitive?

This panel explores why Puerto Rico stands out as a proven and future-ready destination for bioscience investment. Hear directly from industry leaders who have established or expanded operations on the island, and gain insights into manufacturing capabilities, incentives, and the broader innovation ecosystem.

If you’re evaluating U.S. expansion, this conversation will provide a clear perspective on why Puerto Rico isn’t just part of the equation; it’s a strategic advantage.

The biopharmaceutical ecosystem is facing heightened uncertainty, driven by funding constraints, regulatory shifts, and policy reforms—including pricing pressures and the potential expansion of international reference pricing. These dynamics are reshaping dealmaking and raising critical questions for companies pursuing global out‑licensing strategies.

Join experts from Covington for a timely discussion on how these trends are influencing licensing decisions, with insights on:

• Structuring Out‑Licensing Agreements and Territory Splits – strategic and practical considerations
• Policy Impacts on Licensing – Key developments in the U.S. and EU
• Executing Near‑Term Deals – practical guidance in an evolving market

++++++++++++++++++++++ 

This program is accredited for CLE in CA and NY (for both newly admitted and experienced attorneys). Credit will be applied as requested but cannot be guaranteed for VA or WA. The following jurisdictions may accept reciprocal credit: AZ, AR, CT, NJ, and HI. A general certificate of attendance and necessary materials will be provided for all other jurisdictions to support self-application. To receive CLE credit, attendees must complete the CLE Attendance Verification Form within 5 business days of the program. This form must be submitted after the program using the verification code shared during the session. 

++++++++++++++++++++++

Is this the first time you’re attending BIO International Convention? This webinar is for you! You’ll get insider tips from the BIO team on how to maximize your time at BIO 2026 and learn what’s new this year at the largest event for biotechnology in the world. 

If you haven't already registered for BIO 2026, you can find more information on the BIO International Convention website.

At the 2026 BIO International Convention, we come together Driven by Purpose to forge meaningful connections and advance innovations that improve lives. Successful partnering starts with a clear strategy, especially for biotech companies actively seeking licensing deals with pharmaceutical partners.

Join this focused panel discussion featuring pharmaceutical business development executives and biotech leaders pursuing pharma licensing partnerships at BIO 2026. Panelists will share practical, real-world guidance on how both sides approach partnering meetings, assess opportunities and build relationships that lead to successful deals.

In this session, you will hear insights on:

• How to prepare effectively for BIO
• What pharma teams look for in licensing partners and assets
• How biotechs can position their science and data for licensing discussions
• Using the BIO Partnering™ system strategically
• Turning meetings into next steps and deals

Learn directly from industry leaders who know what it takes to partner with purpose and to turn BIO partnering meetings into meaningful licensing outcomes.

Please join the BIO Exhibits and Partnering teams for an informative webinar designed specifically for exhibitors looking to maximize their booth partnering success. 

During this session, we will share practical tips, proven strategies, and best practices to help you optimize your presence, increase visibility, and drive meaningful connections on the exhibit floor.

We look forward to helping you make the most of your partnering opportunities.

​BIO would like to walk through three new offerings to BIO members:

1. BRIDGE – Given the rapidly evolving scientific and regulatory ecosystem, it is critical to have a real-time understanding of any shifts in regulatory predictability, efficiency, or regulator expectations. To address this gap, BIO is introducing BRIDGE (BIO Regulatory Issue Data Gathering & Engagement) to move from anecdotal feedback to a more structured data-collection framework that captures member-reported data on regulatory issues impacting the timely review and approval of an innovative drug or biologic regulated by the FDA. Through BRIDGE, BIO will systematically aggregate member data, identify trend-level regulatory challenges, and engage FDA as needed to improve visibility into areas of recurring friction.
2. Investor Connect Plus – An exclusive investor access program in partnership with LaunchBio for BIO members. This program facilitates targeted one-to-one meetings with institutional and strategic investors actively deploying capital. These monthly efforts will connect Launch Bio’s national network of curated investors with member companies and create meaningful pitch opportunities.
3. Tracxn – Another new partnership, Tracxn offers complimentary access to a database of 250K+ active global investors. A valuable tool to help you identify, screen, and connect with the right partners for your fundraising goals.

The 2026 BIO International Convention is Driven by Purpose—united by our shared mission to push boundaries, solve the impossible and achieve better outcomes for patients, public health, and the world. In that same spirit, BIO Partnering™ is designed to help you turn that purpose into action by connecting with the right partners, collaborators and investors who can help bring your innovations to life.

Join Mackensie Vernetti, BIO’s Vice President of Partnering, for a practical, purpose-driven walkthrough of how to use the BIO Partnering system effectively. This webinar will show you how to:

• Make use of the system’s newest features
• Create a compelling partnering profile that highlights your mission and capabilities
• Identify and evaluate potential partners who align with your goals
• Send targeted, effective meeting requests that lead to meaningful connections
• Manage your schedule and maximize your time at BIO 2026

BIO 2026 is where we return to our essential “why.” This session will help ensure you arrive ready to partner with purpose—and make every meeting count.

BIO is excited to announce BIO Partnering for Oncology, a new partnering opportunity designed to accelerate collaboration and dealmaking across the oncology ecosystem. This partnering event is connecting innovators, investors and companies advancing breakthroughs in cancer research and treatment May 28-June 2 in Chicago, IL. 

To help you get started, join Mackensie Vernetti, BIO’s Vice President of Partnering, for an introductory webinar on using the BIO Partnering™ system, the premier digital platform for finding and scheduling meetings with potential partners. 

In this session, Mackensie will walk you through how to leverage the platform to arrange B2B meetings, including: 

• Build a strong, BD-focused partnering profile 
• Identify and evaluate oncology-specific partnering opportunities
• Send and manage meeting requests effectively
• Maximize your partnering schedule for real results 

Whether you’re seeking new assets, collaborations or strategic alliances, this webinar will help you navigate BIO Partnering for Oncology with confidence, and turn connections into opportunities.

Join Sydney Williams, BIO Senior Manager, Exhibit Sales & Systems, and Ryan Lowry, Manager, Partnering Operations, for a webinar to walk exhibitors through the tools needed to plan for the 2026 BIO International Convention. 

Exhibitors will be provided with the resources to make an impactful presence in San Diego. 

This webinar will cover the following topics: 

• Exhibitor resource center
• Exhibitor tools and resources
• Exhibitor Booth Partnering
• Tips to maximize your event experience in San Diego